Lobular Carcinoma In Situ.

Lobular Carcinoma In Situ.
Surg Pathol Clin. 2018 Mar;11(1):123-145
Authors: Wen HY, Brogi E
Abstract
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is approximately 9 to 10 times that of the general population. Classic LCIS diagnosed on core biopsy with concordant imaging and pathologic findings does not mandate surgical excision, and margin status is not reported. The identification of variant LCIS in a needle core biopsy specimen mandates surgical excision, regardless of radiologic-pathologic concordance. The presence of variant LCIS close to the surgical margin of a resection specimen is reported, and reexcision should be considered.
PMID: 29413653 [PubMed - in process]

Source: Clinical Breast Cancer - February 9, 2018 Category: Cancer & Oncology Authors: Wen HY, Brogi E Tags: Surg Pathol Clin Source Type: research